Senores Pharmaceuticals consolidated net profit rises 21.96% in the September 2026 quarter

Sales rise 25.41% to Rs 192.33 crore

Net profit of Senores Pharmaceuticals rose 21.96% to Rs 39.49 crore in the quarter ended September 2026 as against Rs 32.38 crore during the previous quarter ended September 2025. Sales rose 25.41% to Rs 192.33 crore in the quarter ended September 2026 as against Rs 153.36 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	192.33	153.36	25
OPM %	29.98	32.28	-
PBDT	57.83	48.73	19
PBT	47.58	40.64	17
NP	39.49	32.38	22

Powered by Capital Market - Live News